Sharp margin drop
EBITDA margin dropped 13.2 percentage points in a single year, from 54.9% to 41.7% — worth investigating.
Importance 75 / 95 · anomaly
The strongest observations the engine found, ranked. Every line is generated from the filed numbers by a fixed rule — no opinion, no estimate.
EBITDA margin dropped 13.2 percentage points in a single year, from 54.9% to 41.7% — worth investigating.
Importance 75 / 95 · anomaly
Revenue grew 11.4% but profit declined 25.3%, so the company kept less of each rupee of revenue as profit.
Importance 74 / 95 · growth
Revenue grew 11.4% but only -3.24× of reported profit came through as operating cash.
Importance 62 / 95 · cash quality
Over 5 years the stock returned 39.3% a year while profit compounded at 8.3% a year.
Importance 62 / 95 · business vs stock
Classified by the exchange under Financial Services › Financial Services › Capital Markets › Stockbroking & Allied.
Peer set used on this page: 3 stockbroking & allied.
Revenue grew 21.5% a year over 7 years, from ₹1,217 cr in FY2019 to ₹4,759 cr in FY2026. Net profit grew 16.2% a year over the same period.
Revenue grew 11.4% but profit declined 25.3%, so the company kept less of each rupee of revenue as profit.
Rule PROFIT_SLOWER_THAN_REVENUE
Revenue grew 11.4% but EBITDA margin fell 13.2 percentage points to 41.7%, so the company kept less of each rupee of revenue as operating profit.
Profit has swung sharply over 7 years (from ₹190 to ₹2,508) — one year is a weak guide to the earnings power.
Over 7 years profit compounded at 30.0% a year while revenue compounded at 21.0% a year — though FY2021 saw a one-off step-change of 564% (a merger, restructuring or a recovery off a low base), so the compounding is uneven.
Revenue compounded at 21.0% a year over 7 years (₹2,463 → ₹9,374) — though FY2024 saw a one-off step-change of 69% (a merger, restructuring or a recovery off a low base), so the compounding is uneven.
Net profit fell 25.3% year on year (FY2025 → FY2026).
In Q2 FY27 (Jul–Sep 2026), revenue was ₹3,042 cr (up 64.5% on the same quarter last year) and net profit ₹1,081 cr (up 198%).
Quarterly results, the trailing-twelve-months snapshot, and verified corporate actions — kept separate from each other and from the annual story above. Every figure traces to a filed number; nothing here is external news or commentary.
Q2 FY27 revenue was ₹3,042 cr, up 64.5% from ₹1,849 cr in Q2 FY26 a year earlier.
Rule QTR_REVENUE_GROWTH_YOY
Q2 FY27 net profit was ₹1,081 cr, up 198.3% from ₹363 cr a year earlier.
Rule QTR_PROFIT_GROWTH_YOY
Q2 FY27 net profit grew 198.3% while revenue grew 64.5% vs the same quarter last year — a gap of 133.8 percentage points.
Rule QTR_PROFIT_VS_REVENUE_GROWTH
| Quarter | Revenue | YoY | Net profit | YoY | Net margin |
|---|---|---|---|---|---|
| Q3 FY25 | 1,999 | +12.0% | 566 | −14.4% | 28.3% |
| Q4 FY25 | 1,209 | −43.6% | −63 | −108.7% | −5.2% |
| Q1 FY26 | 2,737 | +18.4% | 1,163 | +31.6% | 42.5% |
| Q2 FY26 | 1,849 | −34.8% | 363 | −67.7% | 19.6% |
| Q3 FY26 | 2,112 | +5.7% | 566 | +0.0% | 26.8% |
| Q4 FY26 | 2,676 | +121.4% | −219 | +246.8% | −8.2% |
| Q1 FY27 | 3,426 | +25.2% | 1,274 | +9.5% | 37.2% |
| Q2 FY27 | 3,042 | +64.5% | 1,081 | +198.3% | 35.6% |
Trailing twelve months to 30 Sept 2026 · sum of the last 4 contiguous quarters
EBITDA margin was 43.5% in FY2026, against 42.4% in FY2019. ROE was 12.2% and ROCE 17.1% in FY2026.
ROE declined from 25.2% to 15.6% year on year.
Rule ROE_DETERIORATED_YOY
EBITDA margin of 41.7% is below the stockbroking and allied median of 62.8%.
EBITDA margin has ranged from 34.8% to 58.4% over 7 years and sits at 41.7% now.
Debt-to-equity was 0.51x in FY2022, against 0.55x in FY2019; interest coverage 2.35x. Operating cash flow was -5.99x net profit.
Revenue grew 11.4% but only -3.24× of reported profit came through as operating cash.
Rule GROWTH_WITH_WEAK_CASH
Net worth compounded at 22.7% a year over 7 years (₹3,094 → ₹12,952).
Within its 3-company Stockbroking & Allied peer group, it ranks 2 of 3 on return on equity and 3 of 3 on EBITDA margin. Its P/E of 27.0 compares with a peer median of 39.4.
Ranked against 3 stockbroking & allied (FY2026, consolidated).
MOTILALOFS · 3rd of 3 · set median 62.8%
MOTILALOFS · 2nd of 3 · set median 15.6%
MOTILALOFS · 1st of 3 · set median 39.4×
Trades at 26.95× earnings — 32% below the stockbroking and allied median of 39.36×.
Rule PE_BELOW_PEERS
On the trailing twelve months. Last full year: P/E 38.9× · P/S 7.7× · ROE 15.6%. TTM and full-year profit and revenue and EBITDA differ by more than 15% — a one-off in a recent quarter is moving the trailing figure; weigh it against the full year.
The share price is up 27.0% over 1 year, up 303% over 3 years (59.2% a year) and up 424% over 5 years (39.3% a year). These are price changes excluding dividends, adjusted for splits and bonuses, to 20 Nov 2026; it is 2.8% below its 52-week high.
Over 5 years the stock returned 39.3% a year while profit compounded at 8.3% a year.
Rule STOCK_RAN_AHEAD
Price-action indicators as of 2026-11-20. Secondary to the fundamentals above — included for timing context, not as a signal.
Observations the engine tagged watch or deteriorating — prompts for your own research, not conclusions.
The full statements, kept deliberately secondary. Every figure traces to a BSE Integrated Filing (inline XBRL); ratios are recomputed from the normalised facts.
| Metric | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,217 | 1,269 | 2,161 | 2,572 | 2,666 | 4,540 | 5,359 | 4,759 |
| Total income | 1,249 | 1,306 | 2,184 | 2,611 | 2,693 | 4,597 | 5,478 | 4,890 |
| EBITDA | 516 | 353 | 1,090 | 1,068 | 993 | 2,306 | 2,627 | 2,070 |
| Profit before tax | 394 | 194 | 837 | 864 | 725 | 1,792 | 1,728 | 1,135 |
| Net profit | 322 | 197 | 712 | 707 | 569 | 1,490 | 1,391 | 923 |
| EPS (₹) | 21.9 | 13.4 | 48.4 | 48.1 | 38.4 | 100.5 | 23.3 | 15.4 |
| Net worth | 2,594 | 2,764 | 3,531 | 4,242 | 4,454 | 5,916 | 7,117 | 7,951 |
| Total debt | 1,420 | 1,430 | 2,079 | 2,171 | — | — | — | — |
| Operating cash flow | — | — | 1 | 879 | −1,332 | −493 | 607 | −5,527 |
| Free cash flow | — | — | −44 | 843 | −1,469 | −623 | 439 | −5,578 |
| Ratio | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| Growth | ||||||||
| Revenue growth YoY | — | 4.3 | 70.3 | 19.0 | 3.7 | 70.3 | 18.0 | -11.2 |
| Profit growth YoY | — | -38.9 | 262.0 | -0.8 | -19.5 | 162.0 | -6.6 | -33.7 |
| Profitability | ||||||||
| EBITDA margin % | 42.4 | 27.8 | 50.4 | 41.5 | 37.2 | 50.8 | 49.0 | 43.5 |
| Net margin % | 25.8 | 15.1 | 32.6 | 27.1 | 21.1 | 32.4 | 25.4 | 18.9 |
| Return on equity % | 12.4 | 7.3 | 22.6 | 18.2 | 13.1 | 28.7 | 21.4 | 12.2 |
| Return on capital % | 12.4 | 7.9 | 21.5 | 17.1 | — | — | — | — |
| Leverage & cash | ||||||||
| Debt to equity | 0.55 | 0.52 | 0.59 | 0.51 | — | — | — | — |
| Cash flow ÷ profit | — | — | 0.00 | 1.24 | -2.34 | -0.33 | 0.44 | -5.99 |
| Current ratio | 1.84 | 1.77 | 1.51 | 1.65 | — | — | — | — |